231 related articles for article (PubMed ID: 19799879)
1. Effects of donepezil on amyloid-beta and synapse density in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Yuede CM; Coughlan CA; Murphy KM; Csernansky JG
Brain Res; 2009 Dec; 1303():169-78. PubMed ID: 19799879
[TBL] [Abstract][Full Text] [Related]
2. Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Csernansky CA; Martin MV; Bertchume A; Vallera D; Csernansky JG
Psychopharmacology (Berl); 2005 Aug; 181(1):145-52. PubMed ID: 15778881
[TBL] [Abstract][Full Text] [Related]
3. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
4. Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer's disease.
Easton A; Sankaranarayanan S; Tanghe A; Terwel D; Lin AX; Hoque N; Bourin C; Gu H; Ahlijanian M; Bristow L
Psychopharmacology (Berl); 2013 Nov; 230(2):279-89. PubMed ID: 23783773
[TBL] [Abstract][Full Text] [Related]
5. Donepezil attenuates Aβ-associated mitochondrial dysfunction and reduces mitochondrial Aβ accumulation in vivo and in vitro.
Ye CY; Lei Y; Tang XC; Zhang HY
Neuropharmacology; 2015 Aug; 95():29-36. PubMed ID: 25744714
[TBL] [Abstract][Full Text] [Related]
6. Spatial relationship between synapse loss and beta-amyloid deposition in Tg2576 mice.
Dong H; Martin MV; Chambers S; Csernansky JG
J Comp Neurol; 2007 Jan; 500(2):311-21. PubMed ID: 17111375
[TBL] [Abstract][Full Text] [Related]
7. Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease.
Wati H; Kawarabayashi T; Matsubara E; Kasai A; Hirasawa T; Kubota T; Harigaya Y; Shoji M; Maeda S
Brain Pathol; 2009 Jan; 19(1):48-57. PubMed ID: 18429966
[TBL] [Abstract][Full Text] [Related]
8. Characterization of cognitive deficits in a transgenic mouse model of Alzheimer's disease and effects of donepezil and memantine.
Nagakura A; Shitaka Y; Yarimizu J; Matsuoka N
Eur J Pharmacol; 2013 Mar; 703(1-3):53-61. PubMed ID: 23276665
[TBL] [Abstract][Full Text] [Related]
9. Granulocyte colony stimulating factor decreases brain amyloid burden and reverses cognitive impairment in Alzheimer's mice.
Sanchez-Ramos J; Song S; Sava V; Catlow B; Lin X; Mori T; Cao C; Arendash GW
Neuroscience; 2009 Sep; 163(1):55-72. PubMed ID: 19500657
[TBL] [Abstract][Full Text] [Related]
10. Does donepezil treatment slow the progression of hippocampal atrophy in patients with Alzheimer's disease?
Hashimoto M; Kazui H; Matsumoto K; Nakano Y; Yasuda M; Mori E
Am J Psychiatry; 2005 Apr; 162(4):676-82. PubMed ID: 15800138
[TBL] [Abstract][Full Text] [Related]
11. Hippocampal administration of chondroitinase ABC increases plaque-adjacent synaptic marker and diminishes amyloid burden in aged APPswe/PS1dE9 mice.
Howell MD; Bailey LA; Cozart MA; Gannon BM; Gottschall PE
Acta Neuropathol Commun; 2015 Sep; 3():54. PubMed ID: 26337292
[TBL] [Abstract][Full Text] [Related]
12. Abeta-degrading endopeptidase, neprilysin, in mouse brain: synaptic and axonal localization inversely correlating with Abeta pathology.
Fukami S; Watanabe K; Iwata N; Haraoka J; Lu B; Gerard NP; Gerard C; Fraser P; Westaway D; St George-Hyslop P; Saido TC
Neurosci Res; 2002 May; 43(1):39-56. PubMed ID: 12074840
[TBL] [Abstract][Full Text] [Related]
13. Effects of memantine on neuronal structure and conditioned fear in the Tg2576 mouse model of Alzheimer's disease.
Dong H; Yuede CM; Coughlan C; Lewis B; Csernansky JG
Neuropsychopharmacology; 2008 Dec; 33(13):3226-36. PubMed ID: 18418360
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent neuroplasticity mechanisms in Alzheimer Tg2576 mice following modulation of brain amyloid-β levels.
Lilja AM; Röjdner J; Mustafiz T; Thomé CM; Storelli E; Gonzalez D; Unger-Lithner C; Greig NH; Nordberg A; Marutle A
PLoS One; 2013; 8(3):e58752. PubMed ID: 23554921
[TBL] [Abstract][Full Text] [Related]
15. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
16. Effect of huprine X on β-amyloid, synaptophysin and α7 neuronal nicotinic acetylcholine receptors in the brain of 3xTg-AD and APPswe transgenic mice.
Hedberg MM; Clos MV; Ratia M; Gonzalez D; Lithner CU; Camps P; Muñoz-Torrero D; Badia A; Giménez-Llort L; Nordberg A
Neurodegener Dis; 2010; 7(6):379-88. PubMed ID: 20689242
[TBL] [Abstract][Full Text] [Related]
17. DL0410 can reverse cognitive impairment, synaptic loss and reduce plaque load in APP/PS1 transgenic mice.
Yang RY; Zhao G; Wang DM; Pang XC; Wang SB; Fang JS; Li C; Liu AL; Wu S; Du GH
Pharmacol Biochem Behav; 2015 Dec; 139(Pt A):15-26. PubMed ID: 26476132
[TBL] [Abstract][Full Text] [Related]
18. Effects of corticotrophin-releasing factor receptor 1 antagonists on amyloid-β and behavior in Tg2576 mice.
Dong H; Wang S; Zeng Z; Li F; Montalvo-Ortiz J; Tucker C; Akhtar S; Shi J; Meltzer HY; Rice KC; Csernansky JG
Psychopharmacology (Berl); 2014 Dec; 231(24):4711-22. PubMed ID: 24862368
[TBL] [Abstract][Full Text] [Related]
19. Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice.
Kukar T; Prescott S; Eriksen JL; Holloway V; Murphy MP; Koo EH; Golde TE; Nicolle MM
BMC Neurosci; 2007 Jul; 8():54. PubMed ID: 17650315
[TBL] [Abstract][Full Text] [Related]
20. Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP/PS1 mice, a model of Alzheimer's disease.
McClean PL; Hölscher C
Neuropharmacology; 2014 Jan; 76 Pt A():57-67. PubMed ID: 23973293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
